Archive for May, 2010

Compounding Experience

Monday, May 24th, 2010

Over 15 Years of Experience Supplying the Pharmacy Compounding Industry

LGM Pharma has extensive knowledge and expertise in supplying suitable products to the pharmacy compounding market.

Our expert knowledge of products allows us to keep a close eye on our competitors. We also adhere to the latest FDA/CVM rulings and regulations that are set for the pharmacy compounding industry, and supply API’s only from cGMP certified and FDA approved supply sources.

Check out our compounding products supply list.

Technical Capability:

  • Accurate shipment paperwork, including all necessary details
  • Accurate product labeling as per latest GMP & FDA stipulations

Extensive Global Logistic Coverage:

  • Global logistic centers
  • Unique forwarding networks throughout all major cities

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

Blog About a Topic

Friday, May 14th, 2010

blog-about-a-topic

We Want to Hear From You!

 

Conducting research?

 

Determining whether a product is right for your project?

 

Submit your comments, questions or give your feedback on our LGM Pharma Blog.

 

Whether you are a lab tech, purchasing agent, pharmacist or a happy customer of ours… we want to hear your suggestions!

 

 

 

New Molecules in Pharma

Friday, May 14th, 2010

LGM Pharma supplies new molecules in pharma for your R&D needs.

In today’s competitive research & development market, speed and competitiveness can make the difference to project success and increased project efficiency. LGM Pharma can help you make that difference. Our goal is to provide fast service and customer feedback.

Check out our YouTube video about New Molecules, and how easy it is to find new molecules in pharma on our website.

We also specialize in providing full sourcing options and support for the widest range of the rarest and newest molecules.

Research Molecules Directory | Research Molecules PDF List

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

Synthetic Peptides

Friday, May 14th, 2010

LGM Pharma has the capability to arrange for the production of any kind of peptides, from milligram to gram amounts and with sequence lengths between five and 50 amino acids. We guarantee that our peptides all are HPLC-purified and analyzed by mass spectrometry. We could also facilitate the synthesis of special peptides with rare amino acids, unnatural amino acids, peptides with fluorescent moieties and biotinylated peptides, as well as the synthesis of long peptides with lengths up to 50 amino acids and more in very good quality, and a microwave peptide synthesizer for fast and larger-scale synthesis of peptides up to gram amounts.

An increasing number of peptides are available within 48 hours after receipt of your order. All other peptides will be provided exclusively for our customers and under very favorable conditions. We are especially competitive in Bioactive Peptides & and GMP generic peptide active pharmaceutical ingredients – Try us!

What is a Synthetic Peptide?

Peptides are chains of amino acids. There are 21 proteinogenic L-a amino acids that, in various combinations and permutations, make up the peptides and proteins of living things. Virtually every life process involves peptides in some way. Their key role is to regulate body functions such as the release of hormones, the regulation of blood sugar levels, bone metabolism and various neurological processes.

Peptides play a key role in the growing segment of biopharmaceuticals. Peptide-based drug targets are being identified at an increasingly rapid pace and a variety of new peptide drugs are being developed as novel therapies for cancer, pain treatment, viral infections, diabetes and a host of endocrine and neurological disorders.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.